BC Platforms has received the SEF.Growth (Swiss Economic Forum Growth) High-Potential Quality label for health data innovation and secure, scalable technology solutions.
This recognition reflects our company’s strong track record and commitment to advancing secure, scalable health data solutions for life sciences and healthcare. The SEF.Growth team noted our innovative product portfolio and focus on enabling medical innovation and efficiency through global health data and analytics as the reasons for the award.
Key strengths and high ratings cited
BC Platforms was recognized for our ability to address key needs in the healthcare and pharma industry segment as well as our ability to deliver exceptional customer value, including providing reliable and secure, compliant access to real-world health data via a scalable business model. SEF.Growth also noted our emphasis on regulatory compliance and continuous improvement, as well as federated health data environments and extensive global partner network, as principal factors in the award decision.
Exceptional customer value: BC Platforms addresses a critical industry need by enabling secure, compliant access to large-scale health and genomic data that accelerates drug development and clinical research. SEF.Growth’s assessment rated the value of the customer benefit as “Outstanding,” noting our ability to reduce cycle times and costs for life sciences organizations.
Federated technology and regulatory compliance: BC Platforms’ federated architecture allows sensitive health data to remain within local jurisdictions while enabling cross-border analysis. This approach aligns with stringent European regulations (e.g., GDPR, EHDS), which are increasingly in demand as healthcare and life sciences companies pursue advanced analytics based on real-world patient data and other complex datasets.
Extensive global data network: BC Platforms has built a proprietary network of over 150 data partners, providing access to more than 187 million patient lives across the UK / Europe, APAC, and the Americas. Our global data partner network was noted as a significant strategic asset that stands out among others in the global technology and health data space.
Strategic alliances with leading technology providers: BC Platforms maintains deep alliance with with technology leaders (AWS, NVIDIA) and channel partners, which supports global scalability and operational excellence. This value chain was highly rated for its architecture and partner relationships, which enable efficient integration and expansion.
This SEF.Growth award recognizes our team’s commitment to novel solutions that help customers and partners unlock the full potential of health data. It’s a strong endorsement of our mission to accelerate innovation and improve outcomes for patients and researchers worldwide, and is a testament to the ingenuity and dedication of our global team.
Mukhtar Ahmed, CEO
About SEF Growth
SEF.Growth is a program managed by the Swiss Economic Forum.
The group evaluates and recognizes companies with strong growth potential and convincing strategies, awarding the “SEF.Growth High-Potential” quality label after a thorough review by an interdisciplinary team of entrepreneurs and experts. Their goal is to highlight and support businesses that demonstrate significant promise in their respective markets.
Do you need to accelerate your research?
Access large‑scale real‑world data securely and compliantly to support faster research and development.
BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India and the UAE
Zurich – 5th, February 2026 BC Platforms, a global leader in healthcare data, technology, and analytics today announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets. The partnership expands BC Platforms’ global data partner